国际皮肤性病学杂志    2005 31 (1): 21-23   ISSN: 2096-5540  CN: 32-1880/R   皮肤源性瘙痒的发病机制和治疗 刘苏俊, 许爱娥 杭州市第三人民医院皮肤科 310009 收稿日期 2004-03-12  修回日期 null  网络版发布日期 null 参考文献  [1] Twycross R, Greaves MW, Handwerker H, et al. Itch:scratching more than the surface. QJM, 2003, 96:7-26. [2] Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptors for itch in human skin. J Neurosci, 1997, 17:8003-8008. [3] Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine:a central neural pathway for itch. Nat Neurosci,2001,4:72-77. [4] Darsow U, Drzezga A, Frisch M, et al. Processing of histamine-induced itch in the human cerebral cortex:a correlation analysis with dermal reactions. J Invest Dermatol, 2000, 115:1029-1033. [5] Stander S, Steinhoff M, Schmelz M, et al. Neurophysiology of pruritus:cutaneous elicitation of itch. Arch Dermatol, 2003, 139:1463-1470. [6] Miyamoto T, Nojima H, Kuraishi Y. Intradermal cholinergic agonists induce itch-associated response via M3 muscarinic acetylcholine receptors in mice. Jpn J Pharmacol, 2002, 88:351-354. [7] Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch:a novel pathway for pruritus in human skin. J Neurosci, 2003, 23:6176-6180. [8] Neisius U, Olsson R, Rukwied R, et al. Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol, 2002, 47:28-32. [9] Johansson O, Liang Y, Emtestam L. Increased nerve growth factorand tyrosine kinase A-like immunoreactivities in prurigo nodularis skin-an exploration of the cause of neurohyperplasia. Arch Dermatol Res,2002, 293:614-619. [10] Grewe M, Vogelsang K, Ruzicka T, et al. Neurotrophin-4 production by human epidermal keratinocytes:increased expression in atopic dermatitis. J Invest Dermatol, 2000, 114:1108-1112. [11] Yosipovitch G, Fleischer A. Itch associated with skin disease:advances in pathophysiology and emerging therapies. Am J Clin Derma tol, 2003, 4:617-622. [12] Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol, 1994, 31:613-616. [13] Weisshaar E, Kucenic MJ, Fleischer AB Jr. Pruritus:a review. Acta Derm Venereol Suppl (Stockh), 2003, (213) :5-32. [14] Miller MJ, Vergnolle N, McKnight W, et al. Inhibition of neurogenic inflammation by the Amazonian herbal medicine sangre de grado. J Invest Dermatol, 2001, 117 i725-730. [15] Yosipovitch G, Sugeng MW, Chan YH, et al. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol, 2001,45:910-913. [16] Freitag G, Hoppner T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr Med Res Opin, 1997, 13:529-537. [17] Fleischer AB Jr. Treatment of atopic dermatitis:role of tacrolimus ointment as a topical noncorticosteroidal therapy. J Allergy Clin lmmunol, 1999, 104:S126-S130. [18] Metze D, Reimann S, Beissert S,et al. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol, 1999,41:533-539. [19] Cather JC, Abramovits W, Menter A. Cyclosporine and tacrolimus in dermatology. Dermatol Clin, 2001, 19:119-137. [20] Wallengren J, Sundler F. Cutaneous field stimulation in the treatment of severe itch. Arch Dermatol, 2001, 137:1323-1325. 通讯作者: